{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:55:09Z","timestamp":1788965709740,"version":"build-2803163510"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Minocycline can induce a rare but serious adverse drug reaction known as drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. We explored the clinical features of minocycline-associated DRESS to aid in early diagnosis and risk mitigation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comprehensive exploration of published cases from the start of electronic databases (PubMed, Embase, Web of Science, CNKI, Wanfang Data) to December 1, 2024. Cases were screened using RegiSCAR criteria.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 3,928 citations were identified through database searches, and after screening, 39 case reports (comprising 57 patients) were included. Fifty-seven patients (mean age 37.1\u00a0years) exhibited median DRESS onset at 17.5\u00a0days. Respiratory symptoms (87.7%, n = 50) dominated, including non-productive cough, dyspnea, pharyngitis, and wheezing. Fever occurred in 45 (78.9%) patients. Median eosinophilia peaked at 4.09 \u00d7 10<jats:sup>9<\/jats:sup>\/L. Symptom improvement median time was 10.5\u00a0days. Overall, forty-five patients (93.8% of 48 with outcome data) recovered post-minocycline discontinuation. Four deaths occurred (hepatic failure, refractory hypotension, unknown causes).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Minocycline-associated DRESS syndrome is characterized by diverse clinical manifestations, including prominent respiratory symptoms. Timely drug cessation, corticosteroid therapy, and vigilant monitoring are critical to optimize outcomes. These findings underscore the need for enhanced pharmacovigilance in high-risk populations.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1515000","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T05:31:26Z","timestamp":1753162286000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical manifestations, diagnostic criteria, and treatment outcomes of minocycline-associated DRESS syndrome: a comprehensive exploration of published cases"],"prefix":"10.3389","volume":"16","author":[{"given":"Yan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiquan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.7326\/0003-4819-85-4-482","article-title":"Minocycline","volume":"85","author":"Allen","year":"1976","journal-title":"Ann. Intern. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jgar.2020.01.022","article-title":"Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: back to the future","volume":"22","author":"Asadi","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.36849\/JDD.6370","article-title":"Fifty years of minocycline and its evolution: a dermatological perspective","volume":"20","author":"Baldwin","year":"2021","journal-title":"J. drugs dermatology JDD"},{"key":"B4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12125","article-title":"A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions","volume":"168","author":"Barbaud","year":"2013","journal-title":"Br. J. dermatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1001\/jamadermatol.2023.4450","article-title":"Management of adult patients with drug reaction with eosinophilia and systemic symptoms: a delphi-based international consensus","volume":"160","author":"Br\u00fcggen","year":"2024","journal-title":"JAMA dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"100673","DOI":"10.1016\/j.waojou.2022.100673","article-title":"DRESS syndrome: a literature review and treatment algorithm","volume":"16","author":"Calle","year":"2023","journal-title":"World Allergy Organ. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.clindermatol.2020.06.008","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"38","author":"Cardones","year":"2020","journal-title":"Clin. dermatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J. Am. Acad. Dermatology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1128\/aac.7.1.46","article-title":"Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline","volume":"7","author":"Chow","year":"1975","journal-title":"Antimicrob. agents Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2174\/1574886316666210120090446","article-title":"Adverse reactions induced by minocycline: a review of literature","volume":"16","author":"Dominic","year":"2021","journal-title":"Curr. drug Saf."},{"key":"B11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/s0049-0172(99)80004-3","article-title":"Minocycline-induced autoimmune syndromes: an overview","volume":"28","author":"Elkayam","year":"1999","journal-title":"Seminars arthritis rheumatism"},{"key":"B12","doi-asserted-by":"publisher","first-page":"Cd002086","DOI":"10.1002\/14651858.CD002086","article-title":"Minocycline for acne vulgaris: efficacy and safety","author":"Garner","year":"2000","journal-title":"Cochrane database Syst. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/tpj.2013.40","article-title":"HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis","volume":"14","author":"Genin","year":"2014","journal-title":"pharmacogenomics J."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.jaip.2022.02.004","article-title":"Drug-induced hypersensitivity syndrome (DIHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis","volume":"10","author":"Hama","year":"2022","journal-title":"J. allergy Clin. Immunol. Pract."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2230367","DOI":"10.1001\/jamanetworkopen.2022.30367","article-title":"Effect of minocycline on depressive symptoms in patients with treatment-resistant depression: a randomized clinical trial","volume":"5","author":"Hellmann-Regen","year":"2022","journal-title":"JAMA Netw. open"},{"key":"B16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1056\/NEJMicm2116076","article-title":"Drug reaction with eosinophilia and systemic symptoms","volume":"387","author":"Hung","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J. Am. Acad. Dermatology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/00007691-198206000-00002","article-title":"Minocycline","volume":"4","author":"Jonas","year":"1982","journal-title":"Ther. drug Monit."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jaad.2013.11.053","article-title":"Comments on: DRESS syndrome","volume":"71","author":"Kardaun","year":"2014","journal-title":"J. Am. Acad. Dermatology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br. J. dermatology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br. J. dermatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1001\/jamadermatol.2022.4519","article-title":"Drug reaction with eosinophilia and systemic symptoms","volume":"159","author":"Krantz","year":"2023","journal-title":"JAMA dermatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1365-2133.2012.10845.x","article-title":"Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature","volume":"166","author":"Lebrun-Vignes","year":"2012","journal-title":"Br. J. dermatology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"757","DOI":"10.3390\/antibiotics10070757","article-title":"A review of systemic minocycline side effects and topical minocycline as a safer alternative for treating acne and rosacea","volume":"10","author":"Martins","year":"2021","journal-title":"Antibiot. Basel, Switz."},{"key":"B25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000112926","article-title":"Minocycline-induced DRESS: evidence for accumulation of the culprit drug","volume":"216","author":"Maubec","year":"2008","journal-title":"Dermatol. Basel, Switz."},{"key":"B26","doi-asserted-by":"publisher","first-page":"adv00102","DOI":"10.2340\/00015555-3465","article-title":"Correlation between expression of CD134, a human herpesvirus 6 cellular receptor, on CD4+ T cells and Th2-type immune responses in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms","volume":"100","author":"Miyagawa","year":"2020","journal-title":"Acta dermato-venereologica"},{"key":"B27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/QCO.0000000000000975","article-title":"Treatment approaches for severe Stenotrophomonas maltophilia infections","volume":"36","author":"Mojica","year":"2023","journal-title":"Curr. Opin. Infect. Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.23750\/abm.v90i3-S.8167","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS) in children","volume":"90","author":"Mori","year":"2019","journal-title":"Acta bio-medica Atenei Parm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/s0090-9556(25)07851-1","article-title":"Metabolism of minocycline in humans","volume":"10","author":"Nelis","year":"1982","journal-title":"Drug metabolism Dispos. Biol. fate Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.2165\/00003088-198815060-00001","article-title":"Clinical pharmacokinetics of doxycycline and minocycline","volume":"15","author":"Saivin","year":"1988","journal-title":"Clin. Pharmacokinet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00228-020-03005-9","article-title":"Antibacterial antibiotic-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a literature review","volume":"77","author":"Sharifzadeh","year":"2021","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.alit.2019.03.006","article-title":"Drug-induced hypersensitivity syndrome (DiHS)\/drug reaction with eosinophilia and systemic symptoms (DRESS): an update in 2019","volume":"68","author":"Shiohara","year":"2019","journal-title":"Allergology Int. official J. Jpn. Soc. Allergology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/17843286.1999.11754231","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)","volume":"54","author":"Tas","year":"1999","journal-title":"Acta Clin. Belg."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7863815","DOI":"10.1155\/2019\/7863815","article-title":"Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review","volume":"2019","author":"Taweesedt","year":"2019","journal-title":"BioMed Res. Int."},{"key":"B35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.jaad.2023.02.072","article-title":"Drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis","volume":"90","author":"Wei","year":"2024","journal-title":"J. Am. Acad. Dermatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.xphs.2020.12.026","article-title":"Antibacterial collagen composite membranes containing minocycline","volume":"110","author":"Wu","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.alit.2019.04.003","article-title":"A case of severe eosinophilic asthma and refractory rheumatoid arthritis well controlled by combination of IL-5R\u03b1 antibody and TNF\u03b1 inhibitor","volume":"68","author":"Yamada","year":"2019","journal-title":"Allergology Int. official J. Jpn. Soc. Allergology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"106678","DOI":"10.1016\/j.ijantimicag.2022.106678","article-title":"In vitro and in vivo efficacy of minocycline-based therapy for Elizabethkingia anophelis and the impact of reduced minocycline susceptibility","volume":"60","author":"Yang","year":"2022","journal-title":"Int. J. Antimicrob. agents"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1515000\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T05:31:29Z","timestamp":1753162289000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1515000\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":38,"alternative-id":["10.3389\/fphar.2025.1515000"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1515000","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]},"article-number":"1515000"}}